These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9702695)

  • 1. Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis.
    Yousry TA; Fesl G; Walther E; Voltz R; Filippi M
    J Neurol Sci; 1998 Jun; 158(2):221-5. PubMed ID: 9702695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose.
    Yousry I; Filippi M; Walther E; Gasperini C; Capra R; Yousry TA
    Magn Reson Imaging; 2000 Nov; 18(9):1183-6. PubMed ID: 11118774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis.
    Gasperini C; Paolillo A; Rovaris M; Yousry TA; Capra R; Bastianello S; Filippi M
    Magn Reson Imaging; 2000 Jul; 18(6):761-3. PubMed ID: 10930786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
    Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
    Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
    Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
    Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis.
    Silver NC; Good CD; Sormani MP; MacManus DG; Thompson AJ; Filippi M; Miller DH
    J Neurol; 2001 Mar; 248(3):215-24. PubMed ID: 11355156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.
    Filippi M; Campi A; Martinelli V; Colombo B; Yousry T; Canal N; Scotti G; Comi G
    J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):540-4. PubMed ID: 8530944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
    Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
    J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI evolution of new MS lesions enhancing after different doses of gadolinium.
    Rovaris M; Mastronardo G; Gasperini C; Prandini F; Yousry TA; Filippi M
    Acta Neurol Scand; 1998 Aug; 98(2):90-3. PubMed ID: 9724005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.
    Filippi M; Rovaris M; Gasperini C; Capra R; Bastianello S; Kuhne I; Yousry TA
    J Neuroimaging; 1998 Apr; 8(2):88-93. PubMed ID: 9557146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
    Filippi M; Capra R; Campi A; Colombo B; Prandini F; Marcianò N; Gasparotti R; Comi G
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):526-30. PubMed ID: 8778257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
    Nomura M; Suzumura A; Anno H; Miyata E; Koga S; Yamamoto H
    Rinsho Shinkeigaku; 1995 Mar; 35(3):225-30. PubMed ID: 7614741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and gadolinium-DTPA MRI evaluation of relapsing remitting multiple sclerosis.
    Capra R; Marcianó N; Cotti Cometti V; Vignolo LA; Bettinzioli M; Airó P; Cattaneo R; Gasparotti R; Moretti R
    Acta Neurol Scand; 1992 Oct; 86(4):342-5. PubMed ID: 1455979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between MRI and short-term clinical activity in multiple sclerosis: comparison between standard- and triple-dose Gd-enhanced MRI.
    Rovaris M; Rodegher M; Comi G; Filippi M
    Eur Neurol; 1999; 41(3):123-7. PubMed ID: 10202242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.
    Thorpe JW; Kidd D; Moseley IF; Kenndall BE; Thompson AJ; MacManus DG; McDonald WI; Miller DH
    Neurology; 1996 Feb; 46(2):373-8. PubMed ID: 8614497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose contrast-enhanced MRI in multiple sclerosis.
    Koudriavtseva T; Pozzilli C; Di Biasi C; Iannilli M; Trasimeni G; Gasperini C; Argentino C; Gualdi GF
    Neuroradiology; 1996 May; 38 Suppl 1():S5-9. PubMed ID: 8811671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics of enhanced gadolinium DTPA brain magnetic resonance images in 298 multiple sclerosis patients].
    Zhang H; Xu XH; Zhao ZG; Guo H; Qiao LY; Yin J; Hou SF; Wei XF; Wen SG; Geng Y; Jiao YJ; Liu JH; Wang H
    Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):490-1. PubMed ID: 12921611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.